Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Guillot

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
Annales De Pediatrie|November 1, 1982
[Results of kidney transplantation in children. Apropos of 213 grafts]M Broyer, M F Gagnadoux, D Beurton, et al.
Journal of Medical Genetics|April 16, 1999
Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitisC Férec, O Raguénès, R Salomon, et al.
Breast Cancer Research and Treatment|July 15, 2009
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independenceLyndsay V Rhodes, Shannon E Muir, Steven Elliott, et al.
Annales De Chirurgie Plastique Et Esthetique|October 2, 2007
[Hand allografts: experience from Lyon team]A Gazarian, D-O Abrahamyan, P Petruzzo, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 8, 2008
[Recommendations for the management of bone demineralization in cystic fibrosis]I Sermet-Gaudelus, R Nove-Josserand, G-A Loeille, et al.
Clinical Colorectal Cancer|March 21, 2023
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized TrialsP Jiménez-Fonseca, J Sastre, P García-Alfonso, et al.
ESMO Open|March 12, 2021
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 studyJ Sastre, P García-Alfonso, J M Viéitez, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Annales De Pediatrie|November 1, 1982
[Results of kidney transplantation in children. Apropos of 213 grafts]M Broyer, M F Gagnadoux, D Beurton, et al.
Journal of Medical Genetics|April 16, 1999
Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitisC Férec, O Raguénès, R Salomon, et al.
Breast Cancer Research and Treatment|July 15, 2009
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independenceLyndsay V Rhodes, Shannon E Muir, Steven Elliott, et al.
Annales De Chirurgie Plastique Et Esthetique|October 2, 2007
[Hand allografts: experience from Lyon team]A Gazarian, D-O Abrahamyan, P Petruzzo, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 8, 2008
[Recommendations for the management of bone demineralization in cystic fibrosis]I Sermet-Gaudelus, R Nove-Josserand, G-A Loeille, et al.
Clinical Colorectal Cancer|March 21, 2023
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized TrialsP Jiménez-Fonseca, J Sastre, P García-Alfonso, et al.
ESMO Open|March 12, 2021
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 studyJ Sastre, P García-Alfonso, J M Viéitez, et al.
Pageof 21